Published in Free Radic Biol Med on July 01, 1999
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res (2009) 3.53
Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 2.19
Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem (2010) 1.41
Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol (2008) 1.06
Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med (2007) 1.06
Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation. Antioxid Redox Signal (2009) 1.06
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol (2008) 1.05
Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. J Agric Food Chem (2008) 1.04
Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr (2012) 1.02
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol (2002) 0.98
Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion (2011) 0.96
Hormetic response of resveratrol against cardioprotection. Exp Clin Cardiol (2010) 0.95
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Hum Mol Genet (2010) 0.94
Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants. Curr Cardiol Rev (2008) 0.93
Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. Exp Mol Pathol (2008) 0.93
Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J Gastroenterol (2008) 0.93
Cardioprotection by sulfaphenazole, a cytochrome p450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species. J Pharmacol Exp Ther (2007) 0.92
Experimental evidence for the cardioprotective effects of red wine. Exp Clin Cardiol (2007) 0.91
Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation. Exp Neurol (2008) 0.91
Resveratrol and the eye: activity and molecular mechanisms. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives. Clin Geriatr Med (2009) 0.90
Resveratrol inhibits the protein expression of transcription factors related adipocyte differentiation and the activity of matrix metalloproteinase in mouse fibroblast 3T3-L1 preadipocytes. Nutr Res Pract (2012) 0.89
Mitochondrial therapeutics for cardioprotection. Curr Pharm Des (2011) 0.89
The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. Molecules (2014) 0.89
Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity. Free Radic Biol Med (2014) 0.87
Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Br J Pharmacol (2006) 0.87
Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.86
Grape seed extract acting on astrocytes reveals neuronal protection against oxidative stress via interleukin-6-mediated mechanisms. Cell Mol Neurobiol (2009) 0.85
Oral administration of grape polyphenol extract ameliorates cerebral ischemia/reperfusion-induced neuronal damage and behavioral deficits in gerbils: comparison of pre- and post-ischemic administration. J Nutr Biochem (2008) 0.85
Organ-Protective Effects of Red Wine Extract, Resveratrol, in Oxidative Stress-Mediated Reperfusion Injury. Oxid Med Cell Longev (2015) 0.83
Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br J Cancer (2004) 0.83
Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet. J Physiol (2015) 0.83
Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity. J Cell Mol Med (2015) 0.83
Red wine: A drink to your heart. J Cardiovasc Dis Res (2010) 0.83
Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice. PLoS One (2015) 0.82
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Invest New Drugs (2009) 0.82
3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways. Evid Based Complement Alternat Med (2011) 0.82
Inhibition of Na⁺-H⁺ exchange as a mechanism of rapid cardioprotection by resveratrol. Br J Pharmacol (2012) 0.82
Antecedent ethanol attenuates cerebral ischemia/reperfusion-induced leukocyte-endothelial adhesive interactions and delayed neuronal death: role of large conductance, Ca2+-activated K+ channels. Microcirculation (2010) 0.81
Structure of trans-resveratrol in complex with the cardiac regulatory protein troponin C. Biochemistry (2011) 0.80
Nutritional Supplement-5 with a Combination of Proteasome Inhibitors (Resveratrol, Quercetin, δ-Tocotrienol) Modulate Age-Associated Biomarkers and Cardiovascular Lipid Parameters in Human Subjects. J Clin Exp Cardiolog (2013) 0.79
Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects. Br J Pharmacol (2014) 0.79
Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits. Evid Based Complement Alternat Med (2012) 0.78
Resveratrol and exercise. Biomed Rep (2016) 0.77
Effects of gallic Acid and cyclosporine a on antioxidant capacity and cardiac markers of rat isolated heart after ischemia/reperfusion. Iran Red Crescent Med J (2014) 0.77
Lignin-derived oak phenolics: a theoretical examination of additional potential health benefits of red wine. J Mol Model (2010) 0.76
Is the protection against ischemia induced by red wine linked to its antioxidant capacity? Exp Clin Cardiol (2001) 0.76
Ethanol for cardiac ischemia: the role of protein kinase c. Ther Adv Cardiovasc Dis (2008) 0.76
Hemidesmus indicus and Hibiscus rosa-sinensis Affect Ischemia Reperfusion Injury in Isolated Rat Hearts. Evid Based Complement Alternat Med (2010) 0.75
Postnatal resveratrol supplementation improves cardiovascular function in male and female intrauterine growth restricted offspring. Physiol Rep (2017) 0.75
TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget (2016) 0.75
Evaluation of Cassia tora Linn. against Oxidative Stress-induced DNA and Cell Membrane Damage. J Pharm Bioallied Sci (2017) 0.75
Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology (2000) 2.58
Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J (2001) 1.68
Cytohistological correlation as a measure of quality assurance of a cytology laboratory. Cytopathology (1997) 1.64
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene (2000) 1.47
Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation (1999) 1.43
High-performance liquid chromatographic peak identification of 2,4-dinitrophenylhydrazine derivatives of lipid peroxidation aldehydes by photodiode array detection. J Chromatogr A (1998) 1.42
Postischemic deterioration of sarcoplasmic reticulum: warm versus cold blood cardioplegia. Ann Thorac Surg (1993) 1.39
Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ Res (1990) 1.39
Reperfusion induced arrhythmias are caused by generation of free radicals. Cardiovasc Res (1994) 1.39
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med (2008) 1.36
Cytomorphological spectrum in scar endometriosis: a study of eight cases. Cytopathology (2005) 1.33
Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React (1995) 1.32
A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol (1992) 1.32
JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation (2001) 1.30
Burkitt-type lymphoma. Diagnosis by fine needle aspiration cytology. Acta Cytol (1987) 1.29
Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol (2001) 1.29
Alpha 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic response in rat left ventricular papillary muscles. Circ Res (1988) 1.28
Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res (1999) 1.28
Effects of resveratrol on the rat brain respiratory chain. Drugs Exp Clin Res (1999) 1.26
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
Fine needle aspiration cytology diagnosis of a cutaneous granular cell tumor in a 7-year-old child. A case report. Acta Cytol (2001) 1.21
H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation (2001) 1.20
Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol (2001) 1.19
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Myocardial protection with red wine extract. J Cardiovasc Pharmacol (2000) 1.14
An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett (1998) 1.14
Use of flyash and biogas slurry for improving wheat yield and physical properties of soil. Environ Monit Assess (2005) 1.12
Natural history of precancerous and early cancerous lesions of the uterine cervix. Acta Cytol (1987) 1.09
Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med (2001) 1.09
Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med (1998) 1.07
Value of radiologically guided fine needle aspiration cytology (FNAC) in the diagnosis of spinal tuberculosis: a study of 29 cases. Cytopathology (1999) 1.06
Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J Mol Cell Cardiol (1999) 1.06
Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol (1998) 1.05
Cytomorphology of hyaline-vascular Castleman's disease: a diagnostic challenge. Cytopathology (2007) 1.05
Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol (1998) 1.02
Molecular adaptation of vascular endothelial cells to oxidative stress. Am J Physiol (1993) 1.02
Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival. Mol Cell Biochem (2001) 1.01
Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React (1996) 1.00
Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation (1997) 1.00
Common and contrasting genomic profiles among the major human lung cancer subtypes. Cold Spring Harb Symp Quant Biol (2005) 1.00
Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun (1989) 1.00
Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr (1998) 1.00
Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett (2000) 1.00
Reactive oxygen metabolites and prooxidant status in children with Down's syndrome. Int J Clin Pharmacol Res (2001) 0.99
Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res (1998) 0.99
Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res (2002) 0.98
Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol (1986) 0.98
Fine-needle aspiration cytology diagnosis of tuberculosis. Diagn Cytopathol (1987) 0.97
Accessory scrotum. Br J Urol (1994) 0.96
Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci Lett (2001) 0.96
Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett (1996) 0.96
SAPKs regulation of ischemic preconditioning. Am J Physiol Heart Circ Physiol (2000) 0.96
Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res (1995) 0.95
The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res (1996) 0.94
Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett (2001) 0.94
Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. Br J Cancer (1990) 0.94
Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury. Chem Biol Interact (1997) 0.93
Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res (1996) 0.93
Differential regulation of Bcl-2, AP-1 and NF-kappaB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett (1999) 0.93
Molluscum contagiosum. A case report with fine needle aspiration cytologic diagnosis and ultrastructural features. Acta Cytol (2000) 0.92
Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. J Cell Mol Med (2002) 0.92
Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation (1993) 0.92
Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol (1995) 0.91
Tolerability and safety of clodronate therapy in bone diseases. Int J Clin Pharmacol Res (1991) 0.91
Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci Lett (1999) 0.91
Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Mol Cell Biochem (1996) 0.91
L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg (1995) 0.91
Increased human papillomavirus infection with the increasing number of pregnancies in Indian women. J Infect Dis (1995) 0.91
Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res (1996) 0.91
Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function. Int J Clin Pharmacol Res (1994) 0.91
Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am J Physiol Heart Circ Physiol (2001) 0.90
1,25-dihydroxyvitamin D(3) dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium. Transplant Proc (2001) 0.90
Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation (1996) 0.90
Differences in bitter taste perception in three strains of rats. Behav Genet (1974) 0.90
Lymphoglandular bodies in lymphoid lesions and non-lymphoid round cell tumours: a quantitative assessment. Diagn Cytopathol (1994) 0.90
HPTLC analysis of sphingomylein, ceramide and sphingosine in ischemic/reperfused rat heart. J Pharm Biomed Anal (1998) 0.90
Pleural effusions in non-Hodgkin's lymphoma. A cytomorphologic, cytochemical and immunologic study. Acta Cytol (1987) 0.90
An analysis of long-term venous access catheters in cancer patients:experience from a tertiary care centre in India. J Postgrad Med (2002) 0.89
Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol (1986) 0.88
Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem (1996) 0.88
Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation (2000) 0.88
Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis. J Cell Mol Med (2008) 0.88
Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem (1998) 0.88
Role of cytokines in myocardial ischemia and reperfusion. Mediators Inflamm (1997) 0.88
An essential role of the antioxidant gene Bcl-2 in myocardial adaptation to ischemia: an insight with antisense Bcl-2 therapy. Antioxid Redox Signal (2001) 0.88